Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,851 | -45,431 | -41,441 | -38,704 | -28,291 |
| Depreciation Amortization | -484 | -194 | -523 | 868 | 2,058 |
| Accounts receivable | 591 | -484 | 483 | -236 | -215 |
| Other Working Capital | 2,719 | 3,172 | 6,568 | -380 | -1,789 |
| Other Operating Activity | 5,102 | 5,244 | 4,026 | 4,632 | 5,197 |
| Operating Cash Flow | $-37,923 | $-37,693 | $-30,887 | $-33,820 | $-23,040 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,386 | 13,808 | 36,777 | 39,041 | -131,243 |
| PPE Investments | -44 | -80 | -582 | -1,006 | -205 |
| Other Investing Activity | 0 | 0 | 0 | 114 | 0 |
| Investing Cash Flow | $1,342 | $13,728 | $36,195 | $38,149 | $-131,448 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,581 | 53,780 | N/A | 75 | 35,450 |
| Financing Cash Flow | $2,581 | $53,780 | $N/A | $75 | $35,450 |
| Beginning Cash Position | 51,470 | 21,655 | 16,347 | 11,943 | 130,981 |
| End Cash Position | 17,470 | 51,470 | 21,655 | 16,347 | 11,943 |
| Net Cash Flow | $-34,000 | $29,815 | $5,308 | $4,404 | $-119,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,923 | -37,693 | -30,887 | -33,820 | -23,040 |
| Capital Expenditure | -44 | -80 | -582 | -1,006 | -205 |
| Free Cash Flow | -37,967 | -37,773 | -31,469 | -34,826 | -23,245 |